Research Department, 541285Fundación Huésped, Buenos Aires, Argentina.
Infectious Diseases Unit, 62916Hospital Juan A. Fernández, Buenos Aires, Argentina.
Int J STD AIDS. 2021 May;32(6):501-509. doi: 10.1177/0956462420979852. Epub 2021 Feb 3.
Little is known of acceptability and feasibility of dual HIV and syphilis rapid tests in community- and home-based provider-initiated strategies among transgender women (TGW), in Latin America. Objectives were (1) to assess the acceptability of this strategy and, (2) to determine the percentage of positive results of HIV and syphilis, analyze the correlates of HIV or syphilis positive results, and measure the rates of effective referral and treatment completion among TGW.
A multidisciplinary team tested 89 TGW in Buenos Aires. An acceptability survey was administered after the HIV/syphilis Duo test was used. All confirmed cases were referred for treatment initiation.
We found high levels of acceptability (98.8%) of this strategy among TGW. However, only 60.7% preferred simultaneous HIV and syphilis diagnosis test. Moreover, we found 9% of positive results of HIV, 51.7% of syphilis, and 3.4% of positive results for both infections. Only not being tested before was associated with an HIV positive result, and only low level of education was associated with a positive syphilis result. Among 8 TGW who tested positive for HIV, 37.5% ( = 3) started antiretroviral therapy. Of 46 who tested positive for syphilis, only 73.9% ( = 34) were effectively referred and from 23 who started treatment, only 39.1% completed it.
Community- and home-based dual HIV and syphilis rapid test is a feasible and highly acceptable approach for this hard-to-reach population. Implementing similar strategies could improve screening uptake and accessibility. However, these results highlight the need to improve strategies for treatment uptake, in order to reduce morbidity and risk of onward transmission.
在拉丁美洲,针对跨性别女性(TGW),社区和家庭为基础的提供者发起的策略中,双 HIV 和梅毒快速检测的可接受性和可行性知之甚少。目的是(1)评估该策略的可接受性,(2)确定 HIV 和梅毒阳性结果的百分比,分析 HIV 或梅毒阳性结果的相关性,并测量 TGW 中有效转诊和治疗完成的比率。
一个多学科团队在布宜诺斯艾利斯测试了 89 名 TGW。在使用 HIV/syphilis Duo 测试后,进行了可接受性调查。所有确诊病例均被转介进行治疗。
我们发现 TGW 对该策略的接受度很高(98.8%)。然而,只有 60.7%的人更喜欢同时进行 HIV 和梅毒诊断检测。此外,我们发现 HIV 阳性率为 9%,梅毒阳性率为 51.7%,两种感染均阳性率为 3.4%。只有之前未接受过检测与 HIV 阳性结果相关,而只有低水平的教育与梅毒阳性结果相关。在 8 名 HIV 检测阳性的 TGW 中,有 37.5%(=3)开始接受抗逆转录病毒治疗。在 46 名梅毒检测阳性的人中,只有 73.9%(=34)得到了有效转诊,而在开始治疗的 23 人中,只有 39.1%完成了治疗。
社区和家庭为基础的双 HIV 和梅毒快速检测对于这个难以接触的人群来说是一种可行且高度可接受的方法。实施类似的策略可以提高筛查的参与度和可及性。然而,这些结果强调需要改善治疗的参与策略,以减少发病率和传播风险。